ECSP066271A - Un método para la preparación de mirtazapina enantioméricamente pura - Google Patents

Un método para la preparación de mirtazapina enantioméricamente pura

Info

Publication number
ECSP066271A
ECSP066271A EC2006006271A ECSP066271A ECSP066271A EC SP066271 A ECSP066271 A EC SP066271A EC 2006006271 A EC2006006271 A EC 2006006271A EC SP066271 A ECSP066271 A EC SP066271A EC SP066271 A ECSP066271 A EC SP066271A
Authority
EC
Ecuador
Prior art keywords
preparation
enantiomerically pure
mirtazapine
acid
pure mirtazapine
Prior art date
Application number
EC2006006271A
Other languages
English (en)
Inventor
Johannes Hubertus Wieringa
De Ven Adrianus Antonius M Van
Gerardus Johnnes Kemperman
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ECSP066271A publication Critical patent/ECSP066271A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La invención provee un método para la preparación de mirtazapina enantioméricamente pura, el cual comprende una etapa de cierre en anillo de un compuesto de la fórmula (II) en donde X es un grupo saliente, comprendiendo dicha etapa un tratamiento con un ácido, en donde se forma mirtazapina con un exceso enantiomérico por medio del cierre en anillo del compuesto de la fórmula (II) con un exceso enantiomérico a través de tratamiento con un ácido adecuado en ausencia de un solvente o con una combinación adecuada de un ácido y de un solvente orgánico.
EC2006006271A 2003-07-10 2006-01-09 Un método para la preparación de mirtazapina enantioméricamente pura ECSP066271A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03102095 2003-07-10

Publications (1)

Publication Number Publication Date
ECSP066271A true ECSP066271A (es) 2006-07-28

Family

ID=34042934

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2006006271A ECSP066271A (es) 2003-07-10 2006-01-09 Un método para la preparación de mirtazapina enantioméricamente pura

Country Status (35)

Country Link
US (2) US8058436B2 (es)
EP (1) EP1656365B1 (es)
JP (1) JP4668184B2 (es)
KR (1) KR20060056315A (es)
CN (1) CN100558722C (es)
AR (1) AR046494A1 (es)
AT (1) ATE433965T1 (es)
AU (1) AU2004255874B2 (es)
BR (1) BRPI0412447A (es)
CA (1) CA2531165C (es)
CO (1) CO5640123A2 (es)
CY (1) CY1109327T1 (es)
DE (1) DE602004021605D1 (es)
DK (1) DK1656365T3 (es)
EC (1) ECSP066271A (es)
ES (1) ES2327123T3 (es)
HR (1) HRP20051019A2 (es)
IL (1) IL172549A0 (es)
IS (1) IS2674B (es)
LT (1) LT5382B (es)
LV (1) LV13441B (es)
MX (1) MXPA06000325A (es)
NO (1) NO20056175L (es)
NZ (1) NZ544360A (es)
PE (1) PE20050323A1 (es)
PL (1) PL1656365T3 (es)
PT (1) PT1656365E (es)
RS (1) RS20050972A (es)
RU (1) RU2352566C2 (es)
SG (1) SG144914A1 (es)
SI (1) SI1656365T1 (es)
TW (1) TWI335915B (es)
UA (1) UA83666C2 (es)
WO (1) WO2005005410A1 (es)
ZA (1) ZA200600019B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102153620A (zh) * 2005-09-26 2011-08-17 住友化学株式会社 光学活性的哌嗪化合物的制造方法
JP5080050B2 (ja) * 2005-09-26 2012-11-21 住友化学株式会社 光学活性なピペラジン化合物の製造方法
TW200808804A (en) * 2006-05-22 2008-02-16 Organon Nv Mirtazapine for the treatment of neuropathic pain
TW200815370A (en) * 2006-06-16 2008-04-01 Organon Nv Stereoselective synthesis of (S)-1-methyl-3-phenylpiperazine
JP5438976B2 (ja) * 2007-02-09 2014-03-12 株式会社カネカ 光学活性２−アリールピペラジン誘導体の製造法
JP5192707B2 (ja) 2007-03-22 2013-05-08 住友化学株式会社 ミルタザピンの製造方法
JP5635905B2 (ja) * 2007-04-11 2014-12-03 メルク・シャープ・エンド・ドーム・ベー・フェー ミルタザピンの調製方法
US7994314B2 (en) 2007-04-11 2011-08-09 N.V. Organon Method for the preparation of an enantiomerically pure benzazepine
KR101485418B1 (ko) * 2013-05-29 2015-01-26 주식회사 메디켐코리아 고순도 미르타자핀의 제조방법
SI3261645T1 (sl) 2015-02-27 2021-08-31 Dechra Limited Stimulacija apetita, uravnavanje izgube mase in zdravljenje anoreksije pri psih in mačkah
KR102540021B1 (ko) * 2020-12-02 2023-06-07 (주)유케이케미팜 대량 생산에 적합한 미르타자핀의 제조방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959470A (en) * 1972-11-28 1976-05-25 Mikhail Davidovich Mashkovsky Psychotropic medicinal preparation
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
CA2026925A1 (en) * 1989-10-05 1991-04-06 Hiroshi Fukumi Tetracyclic compounds having anti-allergic and anti-asthmatic activities, their preparation and use
PT1030667E (pt) 1997-11-14 2005-06-30 Akzo Nobel Nv Utilizacao de mirtazapina para o fabrico de um medicamento para o tratamento de apenas do sono
JPH11222407A (ja) * 1997-11-14 1999-08-17 Sankyo Co Ltd 新規殺菌剤
CN1679586A (zh) * 1999-04-19 2005-10-12 特瓦制药工业有限公司 含哌嗪环化合物的新型合成和结晶方法
US20030069417A1 (en) * 1999-04-19 2003-04-10 Claude Singer Novel synthesis and crystallization of piperazine ring-containing compounds
US6068695A (en) * 1999-07-13 2000-05-30 Bayer Corporation Process for the continuous preparation of quinacridones
WO2001025185A1 (en) 1999-09-30 2001-04-12 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a piperazine derivative
AU6474200A (en) * 1999-12-13 2001-06-18 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound
ES2258071T3 (es) 2000-02-11 2006-08-16 Akzo Nobel N.V. Utilizacion de mirtazepina para trastornos del sueño.
JP2001342188A (ja) * 2000-03-27 2001-12-11 Takeda Chem Ind Ltd 縮合ピラゾール誘導体、その製造法および用途
TW200538100A (en) * 2004-04-21 2005-12-01 Akzo Nobel Nv Mirtazapine salts

Also Published As

Publication number Publication date
PT1656365E (pt) 2009-09-01
IS2674B (is) 2010-09-15
US20100179319A1 (en) 2010-07-15
DE602004021605D1 (de) 2009-07-30
LT5382B (lt) 2006-11-27
WO2005005410A1 (en) 2005-01-20
ZA200600019B (en) 2007-01-31
MXPA06000325A (es) 2006-03-30
EP1656365A1 (en) 2006-05-17
CO5640123A2 (es) 2006-05-31
LV13441B (en) 2006-08-20
LT2005107A (en) 2006-06-27
SI1656365T1 (sl) 2009-10-31
AU2004255874A1 (en) 2005-01-20
JP4668184B2 (ja) 2011-04-13
DK1656365T3 (da) 2009-09-14
US20060229300A1 (en) 2006-10-12
CN1820000A (zh) 2006-08-16
EP1656365B1 (en) 2009-06-17
NO20056175L (no) 2006-01-23
CA2531165A1 (en) 2005-01-20
NZ544360A (en) 2008-05-30
CA2531165C (en) 2011-08-30
CY1109327T1 (el) 2014-07-02
HK1086841A1 (en) 2006-09-29
KR20060056315A (ko) 2006-05-24
PE20050323A1 (es) 2005-05-16
RU2006103992A (ru) 2006-06-27
TW200510426A (en) 2005-03-16
ATE433965T1 (de) 2009-07-15
UA83666C2 (ru) 2008-08-11
AR046494A1 (es) 2005-12-14
US8058436B2 (en) 2011-11-15
RU2352566C2 (ru) 2009-04-20
SG144914A1 (en) 2008-08-28
HRP20051019A2 (en) 2006-02-28
BRPI0412447A (pt) 2006-09-19
IS8184A (is) 2005-12-15
JP2009513537A (ja) 2009-04-02
ES2327123T3 (es) 2009-10-26
AU2004255874B2 (en) 2010-10-28
TWI335915B (en) 2011-01-11
IL172549A0 (en) 2006-04-10
CN100558722C (zh) 2009-11-11
PL1656365T3 (pl) 2009-10-30
RS20050972A (sr) 2008-06-05

Similar Documents

Publication Publication Date Title
CY1109327T1 (el) Μια μεθοδος για την παρασκευη εναντιομερικα καθαρης μιρταζαπινης
CY1115036T1 (el) Μεθοδος για παραγωγη χειραλικων 8-(3-αμινο-πιπεριδιν-1-υλο)-ξανθινων
ECSP10010657A (es) Nuevos compuestos tricíclicos
UY30228A1 (es) Compuestos quimicos
ECSP055913A (es) Inhibidores de las polimerasas víricas
ATE427965T1 (de) Antikírper gegen 25-hydroxyvitamin d
BR112015013822A2 (pt) método de vaso único para a síntese de cu-ssz-13, o composto obtido através do método e utilização do mesmo
DE60333149D1 (de) Verfahren zur Herstellung von organischen elektrolumineszenten Vorrichtungen
TW200740989A (en) Semiconductor wafer cleaning solution, method for cleaning a semiconductor wafer and method for forming an interconnect structure of an integrated circuit
BRPI0611350B8 (pt) formulação, seus usos e seu processo de fabricação,e artigo de fabricação
EA200900397A1 (ru) Новые соединения диосметина, способ их получения и фармацевтические композиции, которые их содержат
WO2008131750A3 (de) Licht emittierendes bauelement und verfahren zum herstellen
CL2011000166A1 (es) Metodo para preparar tetrahidrobiopterina hidrolizando diacetilbiopterina a biopterina en presencia de una base en una mezcla bifasica de agua y solvente organico no miscible en agua e hidrogenando biopterina a tetrahidrobiopterina en presencia de un catalizador, ambas etapas a un ph de al menos 10 (divisional de la solicitud de patente de invencion no. 7-2009).
DE602004024798D1 (de) Herstellung von quetiapin
AR054243A1 (es) Metodos y composiciones para retardar la liberacion de quimicos de tratamiento
TW200732843A (en) Photosensitive resin composition and manufacturing method of semiconductor device using the same
CY1110510T1 (el) Διαδικασια για την παρασκευη δορζολαμιδης
JP2009021575A5 (es)
CL2010000254A1 (es) Procedimiento de sintesis de ivabradina por formacion de una imina; y los compuestos intermediarios considerados en el procedimiento.
UY29110A1 (es) Procedimiento de producción del polisacárido k5
DE602004014264D1 (de) Verfahren zur herstellung von olanzapin
AR048040A1 (es) Metodo de purificacion de mesotriona
ECSP077384A (es) Compuestos tricíclicos que contienen heteroátomos
CO6331375A2 (es) Un proceso para la recuperacion de sulfuro metalico a partir de una solucion que contiene el ion del metal
PA8636101A1 (es) Metodo para la preparacion de acidos hidroxamicos